Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd. This partnership represents Health Robotics' market entry into its 17th new country over the past 20 months, persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous (IV) Admixture Compounding Automation to hospitals all over the world.

"Gamida is very pleased to offer Health Robotics' unique technology to Israel's top medical centers, which have been awaiting for quite a long time to benefit from these technology solutions, much like Oncology patients and Pharmacological teams all over the world have been enjoying with Health Robotics' CytoCare since 2007", stated Moshe Reuveni, Gamida MedEquip's Managing Director.

CytoCare is the first and only robotic system proven to work anywhere in the world for the safe and sterile preparation of Hazardous Intravenous Admixtures, including Chemotherapy, Monoclonal Antibody Therapy, and Gene Therapy. With 67 installations currently under contract in 17 countries, CytoCare has long proven its unmatched flexibility to adapt to diverse pharmacy workflows and proprietary IV consumables in 4 continents. While several companies attempted the development of Chemotherapy Robotics as far back as 22 years ago, Cytocare is still the only robot that has been able to break the entry-barrier into the Intravenous Chemotherapy Automation Sector.

"Since I personally witnessed two years ago at Hadassah Medical Center the outstanding charity-based care delivered to both Palestinian and Israeli Cancer patients, it has been a long time coming for Health Robotics to be in a position to finally deliver our unique technology to tertiary healthcare centers in Israel such as Hadassah and Sheba Medical Center, which had both expressed high interest in our world-leading products a couple of years ago. After an unusually arduous and time-consuming process to find a service partner in Israel, thanks to Gamida, finally Health Robotics is able to deliver our products and services in Israel. My final selection of Gamida over Teva, Lapidot, and several other Israeli-based companies that had entered into negotiations for Health Robotics' exclusive distribution rights in Israel puts an end to a 2-year period of waiting by Israel's top medical centers", stated Gaspar DeViedma, Health Robotics' Executive Vice President.